Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaia Health is a digital therapeutics company focused on evidence-based, software-driven care for musculoskeletal and pulmonary conditions. Its commercial products deliver digital-first rehabilitation and self-management programs through smartphones and tablets, combining exercise therapy, education, breathing and relaxation modules, motion analysis, and human coaching. Kaia’s flagship offerings include Kaia MSK for musculoskeletal pain and Kaia Breathe for COPD-related pulmonary rehabilitation, and the company has also introduced workflow and triage capabilities such as Kaia Gateway. The business primarily serves employers, health plans, and public health systems, with a notable footprint in the United States and Germany. In January 2026, Kaia Health was acquired by Sword Health in a $285 million transaction, after which it continued operating as part of Sword’s broader AI-first care platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaia Health.